Britannia Life Sciences Inc
F:L020
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0165
0.071
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
B
|
Britannia Life Sciences Inc
CNSX:BLAB
|
13m CAD |
Loading...
|
|
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
3.9T INR |
Loading...
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
26.9B CHF |
Loading...
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
18.6B USD |
Loading...
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
85.9B CNY |
Loading...
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
55.4B CNY |
Loading...
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
52B CNY |
Loading...
|
|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
926.1B JPY |
Loading...
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
40.3B CNY |
Loading...
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
5.4B USD |
Loading...
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
3.9B GBP |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Britannia Life Sciences Inc
Glance View
Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Britannia Life Sciences Inc is -58.5%, which is above its 3-year median of -108.3%.
Over the last 3 years, Britannia Life Sciences Inc’s Net Margin has increased from -164.5% to -58.5%. During this period, it reached a low of -922.6% on Mar 31, 2024 and a high of 79.4% on Mar 31, 2023.